March 30, 2025
Game-changing cholesterol news! 🎉 Lepodisiran significantly lowered "bad" lipoprotein(a) levels for up to 6 months in a study – a potential breakthrough for heart health. #cholesterol #hearthealth #medicalbreakthrough #lipoproteinA
Drug shows capacity to reduce 'bad' cholesterol levels - Lepodisiran was able to lower levels of lipoprotein(a) in the participants' blood and this effect lasted from 60-180 days during the study.